- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02685891
Brain Maturation and Sleep (BMS)
January 29, 2024 updated by: University Children's Hospital, Zurich
Exploring Diurnal Changes in Markers of Cortical Plasticity Using Multimodal Imaging in Healthy Children, Adolescents and Adults
In this study, the investigator evaluates whether there are age-specific diurnal changes in markers of cortical plasticity in children, adolescents and adults.
The question will be investigated by the quantification of brain metabolites and structural brain volumes using magnet resonance imaging (MRI) and electrophysiological markers using sleep encephalography (sleep EEG).
In a second step, it will be tested how these markers of cortical plasticity change depending on a modulation of sleep by applying tones during deep sleep.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Given that children and adolescents undergo entirely different maturational processes (children show an increase, adolescents a decrease in synapse density) larger diurnal changes in children are expected compared to adolescents concerning brain metabolites and structural markers.
These cortical changes in synapse density are thought to be reflected in electrophysiological markers in the sleep EEG (children show a higher slow wave activity, adolescents a reduced slow wave activity).
With the modulation of the deep (slow wave) sleep by playing short, low volume tones, the investigators want to test if there is a causal relationship between slow wave sleep and markers of cortical plasticity.
Study Type
Interventional
Enrollment (Estimated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Carina Volk
- Phone Number: +41 44 266 8186
- Email: carina.volk@kispi.uzh.ch
Study Locations
-
-
-
Zurich, Switzerland, 8032
- University Children's Hospital Zurich
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 30 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Male and female subjects 8 to 30 years of age,
- good general health Status
- right-handedness,
- Written informed consent after participants' information
Exclusion Criteria:
- sleep disorders (insomnia, sleep disordered breathing, restless legs syndrome)
- sleep complaints in general
- irregular sleep-wake rhythm
- daytime sleep
- travelling across a time zone within the last month
- diseases or lesions of the central nervous system
- psychiatric diseases
- learning disability
- skin allergy or very sensitive skin
- acute pediatric disease
- pregnancy
- drug and medication use and abuse
- nicotine use
- high caffeine consumption (>2 servings/day (>160 mg caffeine); including coffee, tea, white and dark chocolate, coca cola, energy drink)
- Alcohol consumption in children and adolescents under 16 years
- high alcohol consumption in adults (> 1 standard serving/day (>14 mg Alcohol))
- high alcohol consumption in adolescents aged 16 years and above (> 3-4 Standard servings per week)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: playing tones
During slow-wave sleep short tones (50ms, 50dB) will be played
|
Playing tones time locked to slow waves (Duration:50ms, volume: 50dB)
|
Sham Comparator: Playing no tones
During slow-wave sleep no tones will be played
|
in the sham condition, no tones will be played
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diurnal changes in brain metabolites
Time Frame: 3 years
|
concentration of brain metabolites measured by MR spectroscopy change from evening to morning
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
electrophysiological markers change in dependance of the diurnal variation of brain metabolites
Time Frame: 3 years
|
electrophysiological markers (sleep EEG) change in dependance of the diurnal variation of brain metabolites
|
3 years
|
structural markers change in dependance of the diurnal variation of brain metabolites
Time Frame: 3 years
|
structural markers (MR volumes) change in dependance of the diurnal variation of brain metabolites
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2016
Primary Completion (Estimated)
December 1, 2025
Study Completion (Estimated)
December 1, 2025
Study Registration Dates
First Submitted
February 4, 2016
First Submitted That Met QC Criteria
February 15, 2016
First Posted (Estimated)
February 19, 2016
Study Record Updates
Last Update Posted (Actual)
January 30, 2024
Last Update Submitted That Met QC Criteria
January 29, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- PB_2016-00254
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
-
King's College LondonUniversity of ReadingCompletedHealthy | Healthy AgingUnited Kingdom
Clinical Trials on Playing tones during deep sleep
-
Medical College of WisconsinCompletedThe Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation ExposureBreast Cancer | Invasive Breast Cancer | Ductal Carcinoma in SituUnited States
-
Neurocenter of Southern SwitzerlandCompleted
-
Hôpital RothschildCompletedHealth Knowledge, Attitudes, PracticeFrance
-
Fundacio Catalana de PneumologiaCompletedHypertension | Sleep ApneaSpain
-
Applied CognitionUniversity of Florida HealthCompleted
-
Mayo ClinicTerminatedEpilepsy | Parkinson Disease | Neurological DiseaseUnited States
-
US Department of Veterans AffairsCompletedChronic Fatigue Syndrome | Apnea, SleepUnited States
-
Assistance Publique Hopitaux De MarseilleUnknownRespiratory Disorder in Patient With Gestational DiabetesFrance
-
Aleva Neurotherapeutics SATerminatedParkinson's Disease | Essential TremorSwitzerland
-
Northwestern UniversityCompletedMild Cognitive ImpairmentUnited States